IDO1 and infection: For example, primary nasal epithelial cells treated with the IDO‐1 inhibitor 1‐D‐methyl tryptophan (1‐MT) showed reduced production of pro‐inflammatory cytokines including IL‐7 and G‐CSF upon infection with the PR8 strain of influenza A virus [163].